CRISTINA GARMENDIA

Cristina Garmendia stands as a pivotal figure in European life sciences venture capital, holding the esteemed position of General Partner at Ysios Capital. Ysios Capital is renowned for its strategic investments in groundbreaking companies within the life sciences sector, a domain where Garmendia's expertise truly shines. Her role involves leading investment strategies, identifying high-potential startups, and guiding portfolio companies towards significant growth and impact in areas such as biotechnology, pharmaceuticals, medical devices, and digital health.

At Ysios Capital, Cristina Garmendia is instrumental in shaping the future of healthcare innovation. Her investment focus is keenly directed towards ventures that promise transformative solutions to unmet medical needs, foster scientific breakthroughs, and demonstrate strong commercial viability. She is particularly adept at evaluating complex scientific propositions and translating them into viable investment opportunities, a skill honed by her deep understanding of both scientific research and market dynamics. Under her guidance, Ysios Capital continues to bolster its reputation as a key player in funding the next generation of life sciences leaders.

Garmendia's distinguished career background provides a unique foundation for her contributions to venture capital. Before joining Ysios Capital, she held significant public office, serving as Spain's Minister of Science and Innovation. This experience afforded her an unparalleled perspective on national and international scientific policy, research funding, and the critical interface between science, industry, and government. Prior to her political career, she was a successful entrepreneur, co-founding and leading a biotechnology company, which instilled in her a firsthand understanding of the challenges and triumphs of building a science-based business. Academically, Cristina Garmendia holds a PhD in Biology, further solidifying her scientific credentials and analytical rigor.

While specific individual "notable investments" are often a collective effort within a venture capital firm, Cristina Garmendia has been a driving force behind Ysios Capital's successful portfolio development. Her strategic insights have contributed to the firm's track record of backing innovative companies that have gone on to achieve significant milestones, including successful clinical trials, regulatory approvals, and lucrative exits. She is known for her commitment to fostering innovation that not only generates financial returns but also delivers tangible benefits to patients and healthcare systems worldwide. Her leadership at Ysios Capital continues to reinforce the firm's mission to invest in and build leading life sciences companies that address global health challenges.